Susan Horvath - Oct 1, 2024 Form 4 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role
V.P. of Finance & CFO
Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
Stock symbol
PBLA
Transactions as of
Oct 1, 2024
Transactions value $
$0
Form type
4
Date filed
10/3/2024, 04:26 PM
Previous filing
Mar 29, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PBLA Stock Option (right to buy) Award $0 +25.5K $0.00 25.5K Oct 1, 2024 Common Stock 25.5K $0.39 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option fully vests on October 1, 2025, subject to the Reporting Person's continuous service with the Issuer as of the vesting date.